Clin Nephrol. 2021 Nov;96(5):253-262. doi: 10.5414/CN110459.
Acute kidney injury (AKI) and coagulation disorders are common complications of sepsis that affect its prognosis. However, the relationship between coagulation function and the prognosis of septic AKI has not been fully elucidated.
In this retrospective study, clinical data from patients with septic AKI admitted to the First Affiliated Hospital of Guangxi Medical University from June 2016 to March 2019 were analyzed. Based on clinical outcomes within 60 days, septic AKI patients were divided into a survival and non-survival group, and the survivors were divided into a recovered and non-recovered group depending on renal function.
A total of 338 septic AKI patients were enrolled and followed up; 86 patients died, and 124 patients' renal function did not recover. The all-cause mortality rate in the septic AKI group was higher than in the non-AKI group by 1 : 1 propensity score matching (25.4 vs. 18.9%). The recovery rate for renal function was 50.8% (128/252), and 228 patients (67.5%) had at least one abnormal coagulation index. Logistic analysis indicated that male sex, advanced age, multiple organ dysfunction syndrome, thrombocytopenia, and an increased international standardized ratio (INR) were independent risk factors for all-cause mortality in septic AKI. Concomitant heart disease and prolonged activated partial thrombin time (APTT) were independent risk factors for renal function non-recovery among survivors. Kaplan-Meier curves showed that the cumulative survival rate was lower, and the mean survival time was shorter, in the abnormal coagulation parameter group compared to the normal coagulation parameter group (all p < 0.05).
Many patients with septic AKI have a poor prognosis. Coagulation disorders, including thrombocytopenia, increased INR, and prolonged APTT might predict poor clinical outcomes in patients with septic AKI.
急性肾损伤(AKI)和凝血障碍是脓毒症的常见并发症,影响其预后。然而,凝血功能与脓毒症合并 AKI 的预后之间的关系尚未完全阐明。
本回顾性研究分析了 2016 年 6 月至 2019 年 3 月期间广西医科大学第一附属医院收治的脓毒症 AKI 患者的临床资料。根据 60 天内的临床结局,将脓毒症 AKI 患者分为存活组和非存活组,根据肾功能将幸存者分为恢复组和未恢复组。
共纳入 338 例脓毒症 AKI 患者进行随访;86 例患者死亡,124 例患者肾功能未恢复。脓毒症 AKI 组的全因死亡率高于非 AKI 组(1:1 倾向评分匹配)(25.4%比 18.9%)。肾功能恢复率为 50.8%(128/252),228 例(67.5%)至少有一个异常凝血指标。Logistic 分析表明,男性、高龄、多器官功能障碍综合征、血小板减少和国际标准化比值(INR)升高是脓毒症 AKI 患者全因死亡的独立危险因素。合并心脏病和延长的部分凝血活酶时间(APTT)是幸存者肾功能未恢复的独立危险因素。Kaplan-Meier 曲线显示,异常凝血参数组的累积生存率较低,平均生存时间较短(均 P < 0.05)。
许多脓毒症 AKI 患者预后较差。凝血障碍,包括血小板减少、INR 升高和 APTT 延长,可能预示着脓毒症合并 AKI 患者的临床结局不良。